Skip to main content

Table 2 Assessment of overall survival for stage IIIB colon carcinoma patients by clinicopathological parameters with univariate and multivariate analysis

From: Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

Clinicopaothological characteristics N
(n = 104)
5-year survival Kaplan-Meier analysis
P value
Cox regression model analysis
P value
   64.4%   
Gender    0.461 0.479
   male 65 61.5%   
   female 39 69.2%   
   64.4%   
Age    0.148 0.211
   ≥ 60 year old 57 57.9%   
   <60 year old 47 72.3%   
   64.4%   
Sites of primary mass    0.291 0.381
   Left hemicolon 60 68.3%   
   Right hemicolon 44 59.1%   
   64.4%   
Pathological classifications    0.423 0.139
papillary + tubular 82 65.9%   
mucoid + signet ring 22 59.1%   
   64.4%   
Grades    0.154 0.114
G1 5 60%   
G2 80 68.8%   
G3 19 47.4%   
   64. 4%   
Invasive depth    0.001 0.002
   T3 92 69.6%   
   T4 12 25.0%   
   64.4%   
The percentage of CD133+ cells    0.001 0.004
   ≥5% CD133 positive 42 45.2%   
   <5%CD133 positive 62 77.4%